TAHL CINDY bought FATE
May 6, 2026 · Form 4 insider transaction
TAHL CINDY bought 122,220 shares of Fate Therapeutics, Inc. at $1.32 per share, a transaction worth $161.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
122,220
Price
$1.32
Total value
$161.3K
InsiderTAHL CINDY
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 6, 2026
Filing dateMay 7, 2026
Shares owned after609,301
OwnershipDirect
10b5-1 planNo
AmendedNo